Halaman 2 - Basalioma dalam bahasa medis Indonesia dikenal sebagai Karsinoma Sel Basal Dokter Terbaik - TOP-50 dokter

Dr. Yildiz telah menerbitkan lebih dari 15 artikel peer-reviewed tentang spektrum kanker yang luas di jurnal internasional terkemuka.

• Pengalaman lebih dari 10 tahun di bidang onkologi medis.
• Rekan penulis studi MODEST tentang pengelolaan diabetes pada pasien yang menjalani perawatan terkait kanker.
• Keahlian mencakup tumor neuroendokrin dan sindrom paraneoplastik.
• Publikasi tentang kasus kompleks seperti timoma dan neuroblastoma.
• Bekerja di Rumah Sakit Universitas Medipol Mega di Istanbul.

Dr. Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan saluran pencernaan, dengan pengalaman onkologi yang luas di berbagai rumah sakit di Turki.

• Associate Professor sejak 2016
• Bekerja di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan dan Penelitian Regional Erzurum
• Belajar kedokteran di Universitas Selcuk

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Prof. Paksoy spesialis dalam onkologi medis dengan fokus pada basalioma, menjalankan perannya di Rumah Sakit Medipol Bahçelievler.

• Menyelesaikan pelatihan fellowship dalam onkologi medis di Institut Onkologi Universitas Istanbul
• Mendapatkan sertifikasi ESMO Board dalam Onkologi Medis sejak tahun 2022
• Berpartisipasi aktif dalam berbagai uji klinis internasional untuk berbagai jenis kanker
• Menerbitkan banyak naskah penelitian di bidang onkologi, termasuk karya tentang kanker kulit

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne menghadirkan pendekatan mutakhir dalam pengobatan.

• Pengalaman lebih dari 30 tahun di bidang imunologi
• Kepala Pusat Imunologi Klinis di Rumah Sakit Klinis Universitas Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam

Dr. Alemdar ahli dalam bidang onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz, sebuah institusi terkemuka di Turki.

• Tersertifikasi dalam onkologi medis sejak 2018
• Pengalaman lebih dari 15 tahun di bidang penyakit dalam dan onkologi
• Bekerja di berbagai rumah sakit bergengsi termasuk Rumah Sakit Universitas Akdeniz

Spesialis dalam pengobatan kanker kulit dengan pelatihan fellowship di St John’s Institute of Dermatology di London – pemimpin global dalam onkologi kulit.

• Senior Skin Cancer Fellow di rumah sakit Guy’s dan St Thomas’
• Dosen tentang kanker kulit non-melanoma di King’s College London
• Anggota European Academy of Dermatology and Venereology
• Terlatih dalam teknik bedah dermatologis di Tel-Aviv dan London

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Bergman adalah seorang spesialis dermatologi yang ahli dalam onkodermatologi, berfokus pada diagnosis dan pengobatan kanker kulit seperti basalioma.

• Bekerja di Rambam Medical Center, sebuah rumah sakit besar di Israel
• Memiliki keahlian ganda sebagai spesialis dermatologi dan onkodermatologi
• Spesialisasi dalam kanker kulit, menjadikannya sangat relevan untuk kasus basalioma

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Spesialis dalam onkologi radiasi di Universitas Marmara – berfokus pada perawatan kanker yang presisi.

• Tersertifikasi dalam onkologi radiasi dengan pelatihan khusus selama bertahun-tahun
• Lulusan program medis bahasa Inggris Universitas Marmara
• Bekerja di pusat perawatan kanker Rumah Sakit Emsey

Spesialis dalam prosedur dermatologis tingkat lanjut dengan keahlian dalam perawatan laser dan teknik invasif minimal di Holistic Bio Spa®.

• Asisten medis di klinik dermatologi dengan pengalaman praktis selama 5 tahun
• Mahir dalam mesin laser fraksional dan peremajaan wajah IPL
• Tersertifikasi Biomagnet oleh Higher Institute of Biomagnetism
• Pengalaman luas dengan fototerapi sinar UV untuk kondisi kulit
• Terampil dalam membantu prosedur Botox dan filler